In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.